SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-06-002757
Filing Date
2006-03-16
Accepted
2006-03-16 15:42:21
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. a5100014.htm 10-K 1332047
2 EXHIBIT 10.54 a5100014ex10-54.htm EX-10.54 54411
3 EXHIBIT 10.56 a5100014ex10-56.htm EX-10.56 17744
4 EXHIBIT 10.57 a5100014ex10-57.htm EX-10.57 86856
5 EXHIBIT 23.1 a5100014ex23-1.htm EX-23.1 3469
6 EXHIBIT 31.1 a5100014ex31-1.htm EX-31.1 14601
7 EXHIBIT 31.2 a5100014ex31-2.htm EX-31.2 16474
8 EXHIBIT 32.1 a5100014ex32-1.htm EX-32.1 10509
  Complete submission text file 0001157523-06-002757.txt   1537507
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21696 | Film No.: 06691855
SIC: 2836 Biological Products, (No Diagnostic Substances)